Author

Ayman E. Abdelaziz

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Mentha-mediated selenium nanoparticles attenuate adriamycin-induced chronic kidney disease via multi-target modulation of oxidative, inflammatory, and fibrotic pathways

Highlights • Mentha-mediated SeNPs protect against Adriamycin-induced chronic kidney injury via multi-target molecular modulation.• Green-synthesized SeNPs restore renal function and preserve kidney histoarchitecture in CKD rats.• SeNPs reduce oxidative stress and suppress apoptosis by inhibiting Bax and p53 signaling...

Ayman E. Abdelaziz, A. Shokeir, Basem I. Awad et al. · Biomaterials and Biosystems · 0 citations

Aug 2026

Systems pharmacology, structural modeling, and experimental validation reveal retinoic acid as a modulator of immune-fibrotic networks in chronic kidney disease.

Ayman E. Abdelaziz, A. Shokeir, Basem I. Awad et al. · Naunyn-Schmiedeberg's Archiv... · 0 citations